BioSpace News Archive

BioMidwest

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - October 04, 2022

Veru Inc. announced the granting of inducement awards to seven new employees.

October 4, 2022
·
11 min read
Biotech Bay

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 04, 2022

Olema Pharmaceuticals, Inc. announced that the Company granted stock options to four new employees to purchase an aggregate of 58,300 shares of the Company’s common stock, effective as of October 3, 2022.

October 4, 2022
·
1 min read
Biotech Bay

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 04, 2022

Ultragenyx Pharmaceutical Inc. reported the grant of non-qualified stock options to purchase an aggregate of 13,000 shares of common stock of the company and 6,500 restricted stock units of the company’s common stock to one newly hired non-executive officer of the company.

October 4, 2022
·
2 min read
Policy

Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System

Aurora Spine Corporation announced it has received 510 clearance from the United States Food and Drug Administration for the patented minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System.

October 4, 2022
·
2 min read
Policy

FDA Roundup: October 4, 2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

October 4, 2022
·
4 min read
Pixium Vision announces participation in investor conferences and events in October 2022

Pixium Vision SA announces that senior management will participate in the following investor events in October 2022:

October 4, 2022
·
2 min read
BioMidwest

Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma

Wheeler Bio, a contract development and manufacturing organization specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMC™, announced the first closing of their Series A financing round.

October 4, 2022
·
4 min read
Hayashibara Brings Back “Trehalose Symposium” to Reveal Its Game-changing Versatilities in Human Biochemistry

Hayashibara Co., Ltd., a member of Nagase Group and headquartered in Okayama City, western Japan, hosted the 24th Trehalose Symposium, with the support of the Japanese Society of Applied Glycoscience, on September 8, 2022.

October 4, 2022
·
2 min read
Poolbeg Pharma PLC Announces POLB 001 US Patent update

Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, provides an update on the strengthening of its intellectual property position around POLB 001, a small molecule immunomodulator for the treatment of severe influenza.

October 4, 2022
·
6 min read
Genetown

MilliporeSigma Announces a Boost in Commercial Capacity in France as Part of New Millipore® CTDMO Services

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that its Life Science business sector has opened a commercial facility for its new Millipore® CTDMO Services offering at the company’s site in Martillac, France.

October 4, 2022
·
5 min read